Shelley Shapiro is a Respiratory physician affiliated with VA Greater Los Angeles Healthcare System. OpenAlex indexes 82 publications with 6,669 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza
#365,530,420,120
Los Angeles, CA 90095
Telephone
310-825-8061Registry record last updated 9 Mar 2010.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20252 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
- SCPHARMACEUTICALS INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.6%Endothelin Receptor Antagonist31.8%Ambrisentan53%Opsumit36%Letairis10%Part D<11 patientsSoluble Guanylate Cyclase Stimulator6.4%Adempas100%Part D≥12 patients+ 3 more classes in this area
Genitourinary & hormones
25.7%Phosphodiesterase 5 Inhibitor25.7%Tadalafil72%Adcirca28%Part D≥42 patientsBlood & clotting
15%Prostacycline Vasodilator13.5%Tyvaso Dpi73%Orenitram Er10%Remodulin9%Tyvaso Refill Kit8%Part D<11 patientsProstacyclin Receptor Agonist1.5%Uptravi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
The Lancet Respiratory Medicine
2024 - Tyvaso DPI: Drug-device characteristics and patient clinical considerations
Pulmonary Pharmacology & Therapeutics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
David Sarraf, MD
VA Greater Los Angeles Healthcare System
Joseph Pisegna, MD
VA Greater Los Angeles Healthcare System
David Rigberg, MD
VA Greater Los Angeles Healthcare System
Albert Sattin, MD
VA Greater Los Angeles Healthcare System
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Marshall University
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”